Commentary A new model for ductal carcinoma in situ suggests strategies for

@inproceedings{Gullick2002CommentaryAN,
  title={Commentary A new model for ductal carcinoma in situ suggests strategies for},
  author={William J. Gullick},
  year={2002}
}
Human ductal carcinoma in situ (DCIS) of the breast is now diagnosed quite frequently, due largely to the introduction of mammographic screening. It has been shown in a cell culture system that activation of c-erbB-2, but not the epidermal growth factor receptor, results in a DCIS-like phenotype. Since overexpression of c-erbB-2 occurs in 60% of DCIS, this suggests that it could be a target for treatment in this disease. 

Similar Papers

Loading similar papers…